Results 11 to 20 of about 395,313 (278)
Journal of Immunological Research, 2022 Background. Mycoplasma pneumoniae is a common pathogen of community‐acquired pneumonia (CAP) in children. M. pneumoniae infection is usually regarded as a self‐limiting disease, but in some special cases, it can also develop into refractory Mycoplasma ...
Wanjie Huang +3 more
semanticscholar +1 more source
Immune response plays a role in Mycoplasma pneumoniae pneumonia
Frontiers in Immunology, 2023 Introduction Mycoplasma pneumoniae (MP) is a major pathogen of community-acquired pneumonia in children. However, the specific pathogenesis of the progression of Mycoplasma pneumoniae pneumonia (MPP) is unclear.
Yifan Zhu +15 more
semanticscholar +1 more source
European Journal of Pediatrics, 2023 Early assessment of refractory Mycoplasma pneumoniae pneumonia (RMPP) with plastic bronchitis (PB) allows timely removal of casts using fiberoptic bronchoscopic manipulation, which relieves airway obstruction and limit sequelae development.
Han Zhang +6 more
semanticscholar +1 more source
BMC Pulmonary Medicine, 2023 Backgroud The current diagnostic criteria for refractory Mycoplasma pneumoniae pneumonia (RMPP) among Mycoplasma pneumoniae Pneumonia (MPP) are insufficient for early identification, and potentially delayed appropriate treatment.
Meng Li +9 more
semanticscholar +1 more source
Global research trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric analysis
Frontiers in Pediatrics, 2023 Background Mycoplasma pneumoniae pneumonia (MPP), attributable to Mycoplasma pneumoniae (MP), represents a predominant form of community-acquired pneumonia in pediatric populations, thereby posing a significant threat to pediatric health.
Zheping Song +5 more
semanticscholar +1 more source
Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia
Frontiers in Immunology, 2023 Introduction Mycoplasma pneumoniae pneumonia (MPP) may lead to various significant outcomes, such as necrotizing pneumonia(NP) and refractory MPP (RMPP).
Dan Li +7 more
semanticscholar +1 more source
Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia
Emerging Microbes and Infections, 2023 Although previous studies have reported the dysregulation of respiratory tract microbiota in infectious diseases, insufficient data exist regarding respiratory microbiota imbalances in the lower respiratory tracts (LRTs) of children with Mycoplasma ...
Ya-cui Wang +15 more
semanticscholar +1 more source
Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children
Clinical Respiratory Journal, 2023 Thromboembolism is less common in children than in adults, but it is frequently associated with Mycoplasma pneumoniae infection in many cases. This study aimed to investigate the clinical characteristics of pediatric M.
Lanqin Chen +5 more
semanticscholar +1 more source
Epidemiological features of community-acquired mycoplasma pneumonia
Фундаментальная и клиническая медицина, 2021 Aim. To analyse an epidemic process of community-acquired mycoplasma pneumonia in the Volga Federal District and the Nizhny Novgorod Region.Materials and Methods.
E. A. Koshkarina +6 more
doaj +1 more source
Frontiers in Pharmacology, 2021 Objective: This study was intended to provide data to support the effect of Shashen Maidong Decoction in improving mycoplasma pneumonia in pediatric patients through systematic evaluation.
Jiawei Wang +7 more
semanticscholar +1 more source